KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 124 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $555,000 | -49.5% | 163,226 | -44.1% | 0.00% | – |
| Q2 2018 | $1,098,000 | +44.9% | 292,056 | +57.6% | 0.00% | – |
| Q1 2018 | $758,000 | -44.8% | 185,319 | -37.2% | 0.00% | – |
| Q4 2017 | $1,372,000 | +68.3% | 295,212 | +157.4% | 0.00% | – |
| Q3 2017 | $815,000 | +18.5% | 114,705 | +20.5% | 0.00% | – |
| Q2 2017 | $688,000 | +2.8% | 95,212 | -12.3% | 0.00% | – |
| Q1 2017 | $669,000 | -25.7% | 108,558 | -29.4% | 0.00% | – |
| Q4 2016 | $900,000 | +15.5% | 153,700 | +4.8% | 0.00% | – |
| Q3 2016 | $779,000 | -25.3% | 146,614 | -6.9% | 0.00% | – |
| Q2 2016 | $1,043,000 | +55.4% | 157,532 | +9.6% | 0.00% | – |
| Q1 2016 | $671,000 | -79.5% | 143,738 | -77.8% | 0.00% | – |
| Q4 2015 | $3,269,000 | +2.0% | 647,250 | -28.9% | 0.00% | -100.0% |
| Q3 2015 | $3,206,000 | +42.9% | 910,695 | +305.3% | 0.00% | 0.0% |
| Q2 2015 | $2,243,000 | -30.3% | 224,713 | -11.1% | 0.00% | -50.0% |
| Q1 2015 | $3,218,000 | +198.0% | 252,830 | +231.0% | 0.00% | – |
| Q4 2014 | $1,080,000 | -85.9% | 76,376 | -86.3% | 0.00% | -100.0% |
| Q3 2014 | $7,645,000 | +222.8% | 555,965 | +261.2% | 0.00% | +100.0% |
| Q2 2014 | $2,368,000 | +19.7% | 153,925 | +32.6% | 0.00% | 0.0% |
| Q1 2014 | $1,978,000 | -22.2% | 116,073 | -40.8% | 0.00% | 0.0% |
| Q4 2013 | $2,541,000 | +113.5% | 196,228 | +66.4% | 0.00% | – |
| Q3 2013 | $1,190,000 | +47.3% | 117,905 | +8.9% | 0.00% | – |
| Q2 2013 | $808,000 | – | 108,227 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $3 | 0.00% |